Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlobalworth Regulatory News (GWI)

Share Price Information for Globalworth (GWI)

Share Price is delayed by 15 minutes
Get Live Data
1.70    -0.05 (-2.86%)
Bid:
1.69
Ask:
1.70
Spread: 0.01 (0.592%)
Market Cap: €511.08m
GWI Live PriceLast checked at - London Stock Exchange

Intraday Globalworth Share Chart

S&P - 'BB' Rating affirmed

26 Mar 2026 13:00

RNS Number : 3128Y
Globalworth Real Estate Inv Ltd
26 March 2026
 

FOR IMMEDIATE RELEASE

 

26 March 2026

 

Globalworth Real Estate Investments Limited

("Globalworth" or the "Company")

 

S&P - 'BB' Rating affirmed

Globalworth (AIM: GWI), the leading office investor in Central and Eastern Europe, hereby acknowledges that Standard & Poor's ("S&P") has affirmed Globalworth's 'BB' long-term issuer credit with a Stable outlook.

The Company continues to pursue strategic initiatives designed to optimise its current property portfolio and enhance operational efficiencies, with the objective of improving its interest cover ratio in the long term, and continues to maintain a robust liquidity position.

 

For further information visit www.globalworth.com or contact: 

Enquiries 

Rashid Mukhtar

Group CFO

 

Tel: +40 732 800 000

Panmure Liberum (Nominated Adviser and Broker)

Atholl Tweedie 

Tel: +44 20 7886 2500

 

About Globalworth / Note to Editors: 

Globalworth is a listed real estate company active in Central and Eastern Europe, quoted on the AIM-segment of the London Stock Exchange. It has become the pre-eminent office investor in the CEE real estate market through its market-leading positions both in Poland and Romania. Globalworth acquires, develops and directly manages high-quality office and industrial real estate assets in prime locations, generating rental income from high quality tenants from around the globe. Managed by over 250 professionals across Cyprus, Guernsey, Poland and Romania the combined value of its portfolio is €2.6 billion, as at 31 December 2025. Approximately 98.4% of the portfolio is in income-producing assets, predominately in the office sector, being leased to a diversified array of over 650 national and multinational corporates. In Poland Globalworth is present in Warsaw, Wroclaw, Lodz, Krakow, Gdansk and Katowice, while in Romania its assets span Bucharest, Constanta and Craiova.

 

IMPORTANT NOTICE: This announcement has been prepared for the purposes of complying with the applicable laws and regulations of the United Kingdom and the information disclosed may not be the same as that which would have been disclosed if this announcement had been prepared in accordance with the laws and regulations of any jurisdiction outside of the United Kingdom. This announcement may include statements that are, or may be deemed to be, "forward-looking statements". These forward-looking statements may be identified by the use of forward-looking terminology, including the terms "targets", "believes", "estimates", "plans", "projects", "anticipates", "expects", "intends", "may", "will" or "should" or, in each case, their negative or other variations or comparable terminology, or by discussions of strategy, plans, objectives, goals, future events or intentions. These forward-looking statements include all matters that are not historical facts and involve predictions. Forward-looking statements may and often do differ materially from actual results. Any forward-looking statements reflect the Company's current view with respect to future events and are subject to risks relating to future events and other risks, uncertainties and assumptions relating to the Company's business, results of operations, financial position, liquidity, prospects, growth or strategies and the industry in which it operates. Forward-looking statements speak only as of the date they are made and cannot be relied upon as a guide to future performance. Save as required by law or regulation, the Company disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements in this announcement that may occur due to any change in its expectations or to reflect events or circumstances after the date of this announcement.

A rating is not a recommendation to buy, sell or hold securities and may be subject to revision or withdrawal at any time.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBDGDXRXDDGLL
Date   Source Headline
3rd Jun 20263:11 pmRNSFitch investment grade credit rating maintained
22nd May 202611:39 amRNSSatisfaction of employee share awards and TVR
15th May 20267:00 amRNSNotice of AGM and Availability of Annual Report
24th Apr 20265:35 pmRNSDirector/PDMR Shareholding
2nd Apr 20267:00 amRNSIssue of Scrip Dividend Shares & Admission to AIM
31st Mar 20267:00 amRNSAudited Results FY25, Annual Report, Notice of AGM
26th Mar 20261:00 pmRNSS&P - 'BB' Rating affirmed
19th Mar 20267:00 amRNSScrip Dividend Share Reference Price
27th Feb 20267:01 amRNSInterim Dividend & Scrip Alternative
27th Feb 20267:00 amRNSCondensed Unaudited Results for FY 31 Dec 2025
26th Jan 20261:00 pmRNSPartial Bond Redemption
6th Nov 202511:04 amRNSAppointment of Joint CEOs
23rd Sep 20257:00 amRNSHalf-year Report
28th Aug 20257:01 amRNSInterim Dividend Payment
28th Aug 20257:00 amRNSNotice of Interim Results & Prelim Interim Results
26th Jun 20251:41 pmRNSFitch investment grade credit rating maintained
23rd Jun 202512:42 pmRNSResult of AGM
23rd May 202511:45 amRNSBuy back of Shares into Treasury and TVR
15th May 20257:00 amRNSNotice of AGM
1st May 202511:30 amRNSSatisfaction of employee share awards and TVR
25th Apr 20255:35 pmRNSPulbication of Green Allocations Report
23rd Apr 202512:16 pmRNSExtension of secured bank financing
8th Apr 20253:18 pmRNSIssue of Scrip Dividend Shares & Admission to AIM
27th Mar 20257:00 amRNSScrip Dividend Share Reference Price
25th Mar 20257:00 amRNSPublication of Annual Report and Date of AGM
21st Mar 20253:01 pmRNSS&P - revisions to credit rating and outlook
11th Mar 202511:13 amRNSInterim Dividend & Scrip Alternative
11th Mar 20257:00 amRNSCondensed Unaudited Results for FY 31 Dec 2024
18th Oct 20248:01 amRNSDirector/PDMR Shareholding
2nd Oct 20247:00 amRNSIssue of Scrip Dividend Shares & Admission to AIM
24th Sep 20247:00 amRNSHalf-year Report
19th Sep 20247:00 amRNSScrip Dividend Share Reference Price
16th Sep 20243:54 pmRNSHolding(s) in Company
30th Aug 20247:01 amRNSInterim Dividend & Scrip Alternative
30th Aug 20247:00 amRNSNotice of Interim Results & Prelim Interim Results
6th Aug 20244:10 pmRNSChange of Registered Office
18th Jul 20244:35 pmRNSResults of Tender Offers
11th Jul 20248:15 amRNSLaunch of Tender Offers for Bonds & Trading Updat
1st Jul 202412:01 pmRNSCredit Rating & Change of name of nomad
17th Jun 202410:18 amRNSResult of AGM
31st May 20243:03 pmRNSLogistics Sale Closing & Mandatory Bond Redemption
15th May 202410:14 amRNSNotice of AGM
7th May 202412:21 pmRNSBuyback of shares into treasury and TVR
26th Apr 20247:00 amRNSExchange Offer Final Settlement
22nd Apr 20244:35 pmRNSExchange Offer Final Results
11th Apr 20243:03 pmRNSIssue of Scrip Dividend Shares & Admission to AIM
10th Apr 202411:49 amRNSExchange Offer Early Exchange Deadline Results
3rd Apr 20247:00 amRNSSatisfaction of employee share awards and TVR
28th Mar 20244:25 pmRNSExchange Offer for Outstanding Notes 2025 and 2026
28th Mar 202412:00 pmRNSCorrection - Scrip Dividend Share Reference Price

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.